Genetic Examination of Patients With Primary Multiple Hernia
NCT ID: NCT00979095
Last Updated: 2010-10-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2009-06-30
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis is that patients with multiple hernias have different expression of specific genes compared to the healthy control group.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Ultrasound (US) examination of the abdominal aorta to discover possible abdominal aortic aneurysms.
* Beightons score to evaluate the degree of joint hypermobility.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multiple hernia
Patients with more than 3 primary hernias
No interventions assigned to this group
Control group
Patients without hernias
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Herlev Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Herlev Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jacob Rosenberg, Prof. MD
Role: STUDY_DIRECTOR
Herlev Hospital
Jakob Burcharth, MD
Role: PRINCIPAL_INVESTIGATOR
Herlev Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jacob Rosenberg
Herlev Hospital, Herev, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-D-2008-126
Identifier Type: -
Identifier Source: org_study_id